Latest Industry Updates | Industry News | Company Press Releases
 

Pfizer Announces Mixed Lung Cancer Drug Results

26 August 2010

Print Email

Post to: http://del.icio.us/post?url=http%3a%2f%2fwww.drugdevelopment-technology.com%2fnews%2fnews94391.html&title=Pfizer+Announces+Mixed+Lung+Cancer+Drug+Results Delicious http://digg.com/submit?url=http%3a%2f%2fwww.drugdevelopment-technology.com%2fnews%2fnews94391.html&title=Pfizer+Announces+Mixed+Lung+Cancer+Drug+Results Digg http://reddit.com/submit?url=http%3a%2f%2fwww.drugdevelopment-technology.com%2fnews%2fnews94391.html&title=Pfizer+Announces+Mixed+Lung+Cancer+Drug+Results reddit http://www.facebook.com/sharer.php?u=http%3a%2f%2fwww.drugdevelopment-technology.com%2fnews%2fnews94391.html Facebook http://www.stumbleupon.com/submit?url=http%3a%2f%2fwww.drugdevelopment-technology.com%2fnews%2fnews94391.html&title=Pfizer+Announces+Mixed+Lung+Cancer+Drug+Results StumbleUpon



Related News

DMC completes review of BioSante LibiGel Phase III study
The independent Data Monitoring Committee (DMC) has completed the...

Tekmira begins TKM-Ebola Phase 1 clinical study
Tekmira Pharmaceuticals, a developer of RNA interference (RNAi)...

Avanir Pharmaceuticals reports Phase III data of AVP-923
Avanir Pharmaceuticals has reported safety and efficacy results of...

Cariprazine monotherapy shows efficacy against bipolar I disorder
Forest Laboratories and Gedeon Richter have reported preliminary...

EpiCept files fast track status for AmiKet
EpiCept Corporation has filed a fast track designation with the US Food...

See all news


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.